Filing Details

Accession Number:
0001415889-24-019228
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-03 17:03:25
Reporting Period:
2024-07-01
Accepted Time:
2024-07-03 17:03:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1810182 Alx Oncology Holdings Inc ALXO Pharmaceutical Preparations (2834) 850642577
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1857740 Shelly Pinto C/O Alx Oncology Holdings Inc.
323 Allerton Avenue
South San Francisco CA 94080
Svp, Finance And Cao No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-07-01 1,373 $5.82 93,936 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.77 to $5.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  3. Includes 1,718 shares acquired under the Issuer's employee stock purchase plan on June 28, 2024.